This inventor holds 1 USPTO granted patent. Top assignee: Warner-Lambert Company. Active years: 1985.
Company Filing History:
Years Active: 1985
Title: The Innovations of Donald L Kern
Introduction
Donald L Kern is a notable inventor based in Dearborn, MI (US). He has made significant contributions to the field of antimicrobial and antitumor compounds. His work has led to the development of a unique compound that holds promise for medical applications.
Latest Patents
Kern holds a patent for Guanine-N.sup.7 -oxide, which is a purified isolate of an actinomycete identified as ATCC 39364. This isolate is capable of producing the antimicrobial/antitumor compound 2-amino-1,9-dihydro-6H-purine-6-one-7-oxide, commonly known as guanine-N.sup.7 -oxide. The process involves cultivating isolate ATCC 39364 under aerobic conditions in a culture medium containing assimilable sources of carbon and nitrogen until a substantial amount of the compound is produced. The compound can then be isolated for further use. The patent also discloses pharmaceutical compositions comprising guanine-N.sup.7 -oxide or its pharmaceutically acceptable salts, along with a method for treating microbial infections and tumors in mammals.
Career Highlights
Kern is associated with Warner-Lambert Company, where he has contributed to research and development in the pharmaceutical sector. His innovative work has been instrumental in advancing the understanding of antimicrobial and antitumor agents.
Collaborations
Kern has worked alongside notable colleagues such as James C French and Gerard C Hokanson. Their collaborative efforts have furthered the research in the field of medicinal compounds.
Conclusion
Donald L Kern's contributions to the field of antimicrobial and antitumor research are noteworthy. His patent for guanine-N.sup.7 -oxide showcases his innovative spirit and dedication to advancing medical science.